Image

Elastographic Assessment of Suburethral Tissue in Continent and Incontinent Women

Elastographic Assessment of Suburethral Tissue in Continent and Incontinent Women

Recruiting
18-99 years
Female
Phase N/A

Powered by AI

Overview

Strain elastography (SE) will be utilized as a non-invasive imaging technique to evaluate tissue elasticity and biomechanical properties in women with stress urinary incontinence (SUI) and in continent controls. The primary aim is to determine whether SE can detect differences in paraurethral tissue stiffness between these groups. Given the established role of tissue elasticity in the pathophysiology of SUI, SE will be investigated as a potential diagnostic tool in urogynecological evaluations.

This prospective cohort study will be conducted at a tertiary referral center. All participants will undergo introital two-dimensional (2D) ultrasound in the midsagittal plane at rest. SE will be performed in three predefined suburethral regions of interest (ROIs):

  • internal urethral orifice (IUO) level
  • midurethra (MU) level
  • external urethral orifice (EUO) level

The adipose layer (AL) between the external urethral meatus and the pubic symphysis will serve as the reference tissue, representing the softest anatomical structure in the region.

Descriptive and comparative statistical analyses will be conducted to assess differences in paraurethral tissue stiffness between the study groups.

It is hypothesized that SE will be able to detect differences in paraurethral tissue elasticity, with SUI being associated with increased tissue compliance. The study also aims to determine whether SE can reliably distinguish between varying degrees of tissue stiffness in women with SUI and continent controls.

Pathophysiological focus:

The study will explore key mechanisms underlying SUI, including:

  • Weakened bladder neck support
  • Impaired urethral stabilization due to increased tissue elasticity and collagen degradation
  • While conventional 2D ultrasound provides anatomical information, it does not directly evaluate tissue biomechanics. In contrast, SE enables real-time visualization of tissue elasticity, offering a promising adjunct to traditional urogynecological assessment methods.

Standardization and Protocol

The study will follow a standardized protocol to ensure reproducibility and high-quality data. Key methodological elements include:

  • Minimal probe compression during introital ultrasound to avoid artifacts
  • Bladder emptying prior to examination to eliminate confounding effects
  • Carefully standardized ROI placement across all patients
  • Controlled image acquisition conditions to reduce variability

Future Directions

  • Future research based on this study will aim to:
  • Optimize SE protocols and refine ROI placement strategies
  • Establish clinical cutoff values for differentiating tissue stiffness in SUI vs. continent women
  • Assess the long-term effects of pelvic floor muscle training (PFMT) and vaginal estrogen therapy on paraurethral biomechanics
  • Facilitate the integration of SE into routine urogynecological practice to support early diagnosis and personalized treatment strategies for SUI

Eligibility

Inclusion Criteria:

  • Clinical diagnosis of stress urinary incontinence (SUI) based on patient history, physical examination, and/or urodynamic assessment.

Exclusion Criteria:

  • Pelvic malignancy or history of pelvic radiation therapy
  • Urge urinary incontinence (UUI) or detrusor overactivity
  • Pelvic organ prolapse (POP) stage ≥ II (based on POP-Q classification)
  • Pregnancy or recent postpartum status (less than 6 months postpartum)
  • Neurological disorders affecting bladder function
  • Recurrent urinary tract infections (UTIs) or active lower urinary tract infection
  • Inability to undergo study procedures
  • Cognitive impairment or psychiatric conditions affecting informed consent or compliance

Study details
    Urinary Incontinence
    Urinary Incontinence
    Stress
    Urinary Incontinence (UI)
    Urinary Bladder
    Overactive
    Incontinence
    Overactive Bladder
    Stress Urinary Incontinence
    Stress Urinary Incontinence (SUI)

NCT06933407

Szeged University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.